Evidence map›Paper›PMID 39330570›Full record

ArticleToxics2024

Associations between Urinary Phthalate Metabolites with BDNF and Behavioral Function among European Children from Five HBM4EU Aligned Studies.

Elena Salamanca-Fernández, Lydia Espín-Moreno, Alicia Olivas-Martínez, Ainhoa Pérez-Cantero, José L Martín-Rodríguez, Rafael M Poyatos, Fabio Barbone, Valentina Rosolen, Marika Mariuz, Luca Ronfani and 23 more

Abstract read
In one paragraph

Article in Toxics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Elena Salamanca-FernándezBiomedical Research Center (CIBM), Department of Radiology and Physical Medicine, University of Granada, 18012 Granada, Spain.ORCID 0000-0002-1795-2206
Lydia Espín-MorenoCIBER de Epidemiología y Salud Pública (CIBERESP), 28034 Madrid, Spain.ORCID 0009-0003-4154-7096
Alicia Olivas-MartínezInstituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0001-5237-9815
Ainhoa Pérez-CanteroBiomedical Research Center (CIBM), Department of Radiology and Physical Medicine, University of Granada, 18012 Granada, Spain.
José L Martín-RodríguezInstituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0002-7538-4139
Rafael M PoyatosUnidad de Gestión Clínica de Laboratorios, Hospital Universitario Clínico San Cecilio, 18012 Granada, Spain.
Fabio BarboneDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.
Valentina RosolenCentral Directorate for Health, Social Policies and Disability, Friuli Venezia Giulia Region, Via Cassa di Risparmio 10, 34121 Trieste, Italy.
Marika MariuzDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.
Luca RonfaniDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.ORCID 0000-0001-5710-3914
Ľubica Palkovičová MurínováDepartment of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 831 04 Bratislava, Slovakia.
Lucia FábelováDepartment of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 831 04 Bratislava, Slovakia.ORCID 0000-0002-6633-9096
Tamás SzigetiCenter for Public Health and Pharmacy, Albert Flórián út 2-6, 1097 Budapest, Hungary.ORCID 0000-0001-5078-9503
Réka KakucsCenter for Public Health and Pharmacy, Albert Flórián út 2-6, 1097 Budapest, Hungary.
Amrit K SakhiNorwegian Institute of Public Health, P.O. Box 222, Skøyen, N-0213 Oslo, Norway.
Line S HaugNorwegian Institute of Public Health, P.O. Box 222, Skøyen, N-0213 Oslo, Norway.
Birgitte LindemanNorwegian Institute of Public Health, P.O. Box 222, Skøyen, N-0213 Oslo, Norway.
Janja Snoj TratnikJožef Stefan Institute, 1000 Ljubljana, Slovenia.ORCID 0000-0001-5897-5271
Tina KosjekJožef Stefan Institute, 1000 Ljubljana, Slovenia.ORCID 0000-0002-6421-0344
Griet JacobsVITO GOAL, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium.ORCID 0000-0001-8010-0527
Stefan VoorspoelsVITO GOAL, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium.ORCID 0000-0002-9005-1930
Helena JurdákováDepartment of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovičova 6, Mlynská Dolina, 84215 Bratislava, Slovakia.ORCID 0000-0001-7292-1595
Renáta GórováDepartment of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovičova 6, Mlynská Dolina, 84215 Bratislava, Slovakia.ORCID 0000-0001-6668-5469
Ida PetrovičováDepartment of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, Nabrezie mladeze 91, 94974 Nitra, Slovakia.
Branislav KolenaDepartment of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, Nabrezie mladeze 91, 94974 Nitra, Slovakia.ORCID 0000-0003-1524-1512
Marta EstebanNational Centre for Environmental Health, Instituto de Salud Carlos III, 28034 Madrid, Spain.ORCID 0000-0002-4527-350X
Susana Pedraza-DíazNational Centre for Environmental Health, Instituto de Salud Carlos III, 28034 Madrid, Spain.ORCID 0000-0001-9401-6473
Marike Kolossa-GehringGerman Environment Agency (UBA), Corrensplatz 1, 14195 Berlin, Germany.
Sylvie RemyVITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.ORCID 0000-0003-0322-9620
Eva GovartsVITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.ORCID 0000-0002-6075-4862
Greet SchoetersDepartment of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.ORCID 0000-0002-6556-4814
Mariana F FernándezBiomedical Research Center (CIBM), Department of Radiology and Physical Medicine, University of Granada, 18012 Granada, Spain.ORCID 0000-0001-6417-8914
Vicente MustielesBiomedical Research Center (CIBM), Department of Radiology and Physical Medicine, University of Granada, 18012 Granada, Spain.ORCID 0000-0002-2010-5438

Funding

European Comission HBM4EU 733032European Comission PARC 101057014
6 · The paper itself

Abstract

Based on toxicological evidence, children's exposure to phthalates may contribute to altered neurodevelopment and abnormal regulation of brain-derived neurotrophic factor (BDNF). We analyzed data from five aligned studies of the Human Biomonitoring for Europe (HBM4EU) project. Ten phthalate metabolites and protein BDNF levels were measured in the urine samples of 1148 children aged 6-12 years from Italy (NACII-IT cohort), Slovakia (PCB-SK cohort), Hungary (InAirQ-HU cohort) and Norway (NEBII-NO). Serum BDNF was also available in 124 Slovenian children (CRP-SLO cohort). Children's total, externalizing and internalizing behavioral problems were assessed using the Child Behavior Checklist at 7 years of age (only available in the NACII-IT cohort). Adjusted linear and negative binomial regression models were fitted, together with weighted quantile sum (WQS) regression models to assess phthalate mixture associations. Results showed that, in boys but not girls of the NACII-IT cohort, each natural-log-unit increase in mono-n-butyl phthalate (MnBP) and Mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) was cross-sectionally associated with higher externalizing problems [incidence rate ratio (IRR): 1.20; 95% CI: 1.02, 1.42 and 1.26; 95% CI: 1.03, 1.55, respectively]. A suggestive mixture association with externalizing problems was also observed per each tertile mixture increase in the whole population (WQS-IRR = 1.15; 95% CI: 0.97, 1.36) and boys (IRR = 1.20; 95% CI: 0.96, 1.49). In NACII-IT, PCB-SK, InAirQ-HU and NEBII-NO cohorts together, urinary phthalate metabolites were strongly associated with higher urinary BDNF levels, with WQS regression confirming a mixture association in the whole population (percent change (PC) = 25.9%; 95% CI: 17.6, 34.7), in girls (PC = 18.6%; 95% CI: 7.92, 30.5) and mainly among boys (PC = 36.0%; 95% CI: 24.3, 48.9). Among CRP-SLO boys, each natural-log-unit increase in ∑DINCH concentration was associated with lower serum BDNF levels (PC: -8.8%; 95% CI: -16.7, -0.3). In the NACII-IT cohort, each natural-log-unit increase in urinary BDNF levels predicted worse internalizing scores among all children (IRR: 1.15; 95% CI: 1.00, 1.32). Results suggest that (1) children's exposure to di-n-butyl phthalate (DnBP) and di(2-ethylhexyl) phthalate (DEHP) metabolites is associated with more externalizing problems in boys, (2) higher exposure to DINCH may associate with lower systemic BDNF levels in boys, (3) higher phthalate exposure is associated with higher urinary BDNF concentrations (although caution is needed since the possibility of a "urine concentration bias" that could also explain these associations in noncausal terms was identified) and (4) higher urinary BDNF concentrations may predict internalizing problems. Given this is the first study to examine the relationship between phthalate metabolite exposure and BDNF biomarkers, future studies are needed to validate the observed associations.

Indexed as

BDNFbehavioreffect biomarkerexposure biomarkerHBM4EUPARCphthalate

Identifiers

PMID39330570
PMCPMC11436069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.